معرفی
Steven L. Stice is the D.W. Brooks Distinguished Professor and Georgia Research Alliance Eminent Scholar in Animal Reproductive Physiology at the University of Georgia. He serves as Director of the Regenerative Bioscience Center and co-leads the NSF-funded $50M Engineering Research Center for Cell Manufacturing Technologies (CMaT). His work bridges academia and industry as co-founder of five biotech companies, including Aruna Biomedical, which has achieved FDA clearance for the first U.S. clinical trial using exosomes to treat acute ischemic stroke.
- BS, University of Illinois
- MS, Iowa State University
- PhD, University of Massachusetts
Dr. Stice's research focuses on regenerative medicine, exosome technology, and neurological disease treatment. His lab develops neural stem cell-derived extracellular vesicles for brain repair after stroke or traumatic injury, with emphasis on cell-based assays for drug discovery.
His recent publications highlight advancements in exosome therapeutic delivery, stroke recovery models, and metabolomic approaches to cell therapy potency. Key collaborations include Regenerative Engineering and Medicine (REM) with Emory and Georgia Tech, and leadership roles at the FDA Scientific Advisory Board.
- 225+ scholarly articles
- 14,000+ citations
- 67 international patents
- 16 U.S. patents
- National Academy of Inventors Fellow
- Regents’ Entrepreneur distinction
- National Football Foundation Distinguished American Award
- Southeastern Conference Faculty Achievement Award
Dr. Stice mentors through the Regenerative Bioscience Center, which involves 35+ researchers across six colleges. His work has attracted major funding from NIH, NSF, DARPA, and the Bill & Melinda Gates Foundation.
